Peptides

Papers
(The H4-Index of Peptides is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Chemical modifications to increase the therapeutic potential of antimicrobial peptides83
Nisin—A lantibiotic with immunomodulatory properties: A review57
Immunomodulatory peptides—A promising source for novel functional food production and drug discovery54
GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation53
An update on peptide-based therapies for type 2 diabetes and obesity45
The critical role of CCK in the regulation of food intake and diet-induced obesity43
An overview of the insulin signaling pathway in model organisms Drosophila melanogaster and Caenorhabditis elegans39
Antiviral peptides against Coronaviridae family: A review38
Soybean proteins/peptides: A review on their importance, biosynthesis, vacuolar sorting, and accumulation in seeds37
Antimicrobial peptides in domestic animals and their applications in veterinary medicine30
Melanin-concentrating hormone and food intake control: Sites of action, peptide interactions, and appetition30
Peptides to combat viral infectious diseases29
Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy28
Peptides in the regulation of glucagon secretion27
Effects of microbiome changes on endocrine ghrelin signaling – A systematic review27
Arginine vasopressin: Direct and indirect action on metabolism25
Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation24
PACAP orchestration of stress-related responses in neural circuits23
Vasopressin and copeptin release during sepsis and septic shock23
An insight into biological activities of native cyclotides for potential applications in agriculture and pharmaceutics23
Whether short peptides are good candidates for future neuroprotective therapeutics?22
Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists21
Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway21
0.050471067428589